The Growth in Microfluidic Components Market is driven by rising demand for point-of-care testing, technological advancements, increasing focus on data precision and accuracy, fast return on investments, growing demand for miniature portable devices, and growing demand for consumer electronics and wearable devices.
According to the new market research report “Microfluidic Components Market by Product (Valve, Solenoid Valve, Check Valve, Nozzle, Tubing, Micropump, Microneedle, Shuttle Valve), Industry (Automotive, Aerospace & Defense, Healthcare, Consumer Electronics, Oil & Gas) – Global Forecast” published by MarketsandMarkets™, is projected to reach USD 6.1 billion by 2024 from USD 3.3 billion in 2019, at a CAGR of 12.7%.
- In December 2017, Parker launched VSO LowPro GC, a microfluidic valve.
- In 2018 Parker Aerospace, a business segment of Parker Hannifin Corporation, opened its second global Customer Response Center (CRC) in Singapore, with the aim to provide more local insights and potentially faster resolution of issues.
- In December 2017, IDEX Health and Science acquired thinXXS, a manufacturer of disposable microfluidic components for the point of care, veterinary and life science markets.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=223516809
Geographically; the microfluidic components market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Increasing industrialization, investments in water infrastructure, growth in various industries (such as chemicals, power & energy, and aerospace), increasing number of infrastructural development projects (especially in China and India), rising standard of living, and growing urbanization are factors driving the adoption of microfluidic components in the Asia Pacific.
Key Market Players:
The prominent players in the global microfluidic components market are Parker Hannifin Corporation (US), IDEX Corporation (US), Fluigent SA (France), Staiger GmbH & Co. KG (Germany), SMC Corporation (Japan), Camozzi Automation Spa Società Unipersonale (Italy), Aignep s.p.a. (Italy), FIM Valvole Srl (Italy), Humphrey Products Corporation (US), The Lee Company (US), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), and Christian Bürkert GmbH & Co. KG (Germany).
IDEX Corporation is one of the leading players in the microfluidics components market, owing to its broad range of offerings in the valves, micropumps, and sensors segments. It is involved in the design, production, and distribution of small-scale & highly precise fluidics components and sub-assemblies used in analytical and diagnostics instruments, as well as medical equipment and implantable devices. The firm largely focuses on acquiring and partnering with companies that complement its fluidics and microfluidics businesses. IDEX Health & Science has an international network of direct sales professionals and distribution partners in many countries across the globe. The company has manufacturing operations in more than 20 countries.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223516809
Market Segmentation in Detailed:
Solenoid valves segment is expected to grow at a higher CAGR
Based on valve type, the microfluidic components market is segmented into solenoid valves, flow control valves, check valves, shuttle valves, pressure relief valves, proportional valves, and other valves. Solenoid valves are expected to grow at the highest CAGR during the forecast period due to factors like increased application scope in the automotive industry, the shift towards renewable sources for power generation, growing investments in various industries, and increasing government regulations on end-use industries across developing economies.
The healthcare segment is expected to account for the largest share of the microfluidic components market in 2019
The healthcare industry segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as, high healthcare spending, growing demand for process automation, rising government funding in the healthcare sector, growing demand for point-of-care testing, and demand for enhanced safety.